< Back to previous page

Publication

Ibrutinib for first-line treatment of chronic lymphocytic leukemia in patients aged >= 65 year of age : results with 5 years of follow-up for the RESONATE-2 study

Book Contribution - Book Abstract Conference Contribution

Book: LEUKEMIA & LYMPHOMA
Volume: 61
Pages: 38 - 40
Publication year:2020